$0.09
0.00 (+5.88%)
Neose Technologies, Inc. (NTEC)
CAPS Rating:
A clinical stage biopharmaceutical company focused on the development of next-generation therapeutic proteins.
No one has written a Pitch for NTEC stock yet. Tell us why you think NTEC will outperform or underperform the S&P 500.
RSS Headlines
Fool UK
